Valproic acid relieved marked rigidity in three patients with end-stage parkinsonism

Clinical Neurology

Volumn 38, Issue 6, 1998, Pages 495-498

  Sayama, Setsuko ^a   Fujimoto, Ken Ichi ^a   Nakano, Imaharu ^b  

^a Natl Sanatorium Ashikaga Hospital

^b JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Parkinsonism; Rigidity; Valproic acid

Indexed keywords

4 AMINOBUTYRIC ACID; AMANTADINE; CARBIDOPA PLUS LEVODOPA; LEVODOPA; PERGOLIDE; TALIPEXOLE; VALPROIC ACID;

ARTICLE; CASE REPORT; DISEASE SEVERITY; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG MECHANISM; GABAERGIC SYSTEM; HUMAN; MYOTATIC REFLEX; NERVE DEGENERATION; NIGRONEOSTRIATAL SYSTEM; PARKINSON DISEASE; PARKINSONISM; PURKINJE CELL; RIGIDITY; TENDON REFLEX; TERMINAL DISEASE; VESTIBULAR NUCLEUS;

AGED; FEMALE; GABA AGENTS; HUMANS; MIDDLE AGED; MUSCLE RIGIDITY; PARKINSON DISEASE; TREATMENT OUTCOME; VALPROIC ACID;

EID: 0031738801     PISSN: 0009918X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Browne TR : Valproic acid. N Eng J Med 302 : 661-666, 1980
2. Pinder RM, Brogden RN, Speight TM, et al : Sodium valproate : a review of its pharmacological properties and therapeutic efficacy in epilepsy. Drugs 13 : 81-123, 1977
3. Bergman H, Wichmann T, DeLong MR: Reversal of experimental Parkinsonism by lesion of the subthalamic nucleus. Science 249 : 1436-1438, 1990
4. Price PA, Parkes JD, Marsden CD : Sodium valproate in the treatment of levodopa-induced dyskinesia. J Neurol Neurosurg Psychiatry 41 : 702-706, 1978
5. Nutt J, Williams A, Plotkin C, et al : Treatment of Parkinson's disease with sodium valproate : clinical, pharmacological, and biochemical observations. Can J Neurol Sci 6 : 337-343, 1979
6. Fujimoto K, Uyeno N, Takeuchi Y, et al : Participation of the vestibulospinal system in production of the rigidity in patients with basal-ganglia disorders (abstr). Mov Disord 11 supple 1 : 134, 1996
7. Ito M, Yoshida M : The origin of cerebellar-induced inhibition of Deiters neurones I. Monosynaptic initiation of the inhibitory postsynaptic potentials. Exp Brain Res 2 : 330-349, 1966
8. Obata K, Ito M, Ochi R. et al : Pharmacological properties of the postsynaptic inhibition by Purkinje cell axons and the action of γ-aminobutyric acid on Deiters neurons. Exp Brain Res 4 : 43-57, 1967
9. Hyman NM, Dennis PD, Sinclair KGA : Tremor due to sodium valproate. Neurology 29 : 1177-1180, 1979
10. Sasso E, Delsoldato S, Negrotti A, et al : Reversible valproate-induced extrapyramidal disorders. Epilepsia 35 : 391-393, 1994
11. Armon C, Shin C, Miller P, et al : Reversible parkinsonism and cognitive impairment with chronic valproate use. Neurology 47 : 626-635, 1996